<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="196872">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00528125</url>
  </required_header>
  <id_info>
    <org_study_id>SG-07-H-02</org_study_id>
    <nct_id>NCT00528125</nct_id>
  </id_info>
  <brief_title>Laser Acupuncture for Pain Prevention in Neonates</brief_title>
  <official_title>Laser Acupuncture for Pain Prevention in Neonates Undergoing Heel Prick. A Prospective, Randomized, Double-Blinded Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Children Hospital Homburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Children Hospital Homburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain prevention and/or therapy in neonates is still a challenge. It is widely accepted that
      early pain experience can have a tremendous impact on the pain memory. We want to
      investigate if a simple, fast method, that is nearly devoid of side effects can lead to a
      significant alleviation of pain sensation in neonates. Acupuncture has been shown to be
      effective in various painful conditions. Trials on acupuncture in children are rare. Trials
      on acupuncture in neonates are lacking so far. Our hypothesis is that neonates in the active
      laser group experience less pain than those in the placebo group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score (NIPS, PIPP, KUSS) according to a video analysis</measure>
    <time_frame>5 minutes from the heel prick</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active laser acupuncture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo laser acupuncture</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>active laser acupuncture</intervention_name>
    <description>low level laser acupuncture, 830 nm, 30 mW, 0,3 J per acupoint, 2 points per neonate (Hegu and Shen Men). Overall 30 seconds of treatment</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Modulas Handy 2/99, schwamedico, Ehringshausen, Germany</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placebo laser acupuncture</intervention_name>
    <description>placebo laser acupuncture at two acupoints (Hegu, Shen Men). Overall treatment time 30 seconds.</description>
    <arm_group_label>B</arm_group_label>
    <other_name>placebo laser, Modulas Handy 2/99, schwamedico, Ehringshausen, Germany</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neonates with no obvious underlying disease (genetic (e.g. M. Down), metabolic)and
             not under pain medication

        Exclusion Criteria:

          -  Older than 28 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven Gottschling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children Hospital Homburg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ludwig Gortner, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Children Hospital Homburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Children Hospital Homburg</name>
      <address>
        <city>Homburg</city>
        <state>Saarland</state>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <lastchanged_date>March 19, 2008</lastchanged_date>
  <firstreceived_date>September 11, 2007</firstreceived_date>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
